0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > IFN-gamma

IFN-gamma

Brief Information

Name:Interferon gamma
Target Synonym:Immune interferon,Interferon gamma,IFNG,IFN-Gamma,IFG,IFI,Interferon-gamma
Number of Launched Drugs:3
Number of Drugs in Clinical Trials:9
Lastest Research Phase:Approved

Product ListCompare or Buy

Par statut du produit :
Par catégorie de produit :
Par espèce :
Cat . Non Espèces Description du produit Structure Pureté Caractéristique
IFN-BLM412 Mouse Biotinylated Monoclonal IFN-gamma Antibody, Human IgG1 (8C5F8)
IFN-BLM412-sds
RAS-SP002 Mouse Mouse Interferon-γ (IFN-γ) ELISPOT Kit
RES-A028 Human resDetect™ Human Interferon-γ(IFN-γ) ELISA Kit (Residue Testing)
GMP-IFGH24 Human GMP Human IFN-gamma Protein
GMP-IFGH24-structure
GMP-IFGH24-sds
RAS-SP001 Human Human Interferon-γ (IFN-γ) ELISPOT Kit
CFA-C001 Human Human IFN-γ Kit (Flow Cytometry Beads Assay)
CRS-A017 Human ClinMax™ Human Interferon-γ (IFN-γ) ELISA Kit
CRS-D001 Human Human Interferon-γ (IFN-γ) ELISA Assay Pair
IFG-M52H3 Mouse Mouse IFN-gamma / IFNG Protein, His Tag (MALS verified)
IFG-M52H3-structure
IFG-M52H3-sds
IFN-BS138 Mouse Biotinylated Monoclonal Anti-IFNγ Antibody, Mouse IgG1 (13E6H6) (MALS verified)
IFN-BS138-sds
IFN-S120 Mouse Monoclonal Anti-IFNγ Antibody, Mouse IgG2a (8C5F8)
IFN-S120-sds
IFN-BM411 Mouse Biotinylated Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H4) (MALS verified)
IFN-BM411-sds
IFN-S138 Mouse Monoclonal Anti-IFNγ Antibody, Mouse IgG1 (13E6H6)
IFN-S138-sds
CEA-C006 Human ClinMax™ Human IFN-γ ELISA Kit, PRO
IFN-M412 Mouse Monoclonal Anti-IFNγ Antibody, Human IgG1 (8C5F8)
IFN-M412-sds
IFN-M411 Mouse Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H4)
IFN-M411-sds
IFN-M414 Mouse Monoclonal Anti-IFNγ Antibody, Human IgG1 (13E6H6)
IFN-M414-sds
IFG-H4211 Human Human IFN-gamma / IFNG Protein, premium grade
IFG-H4211-structure
IFG-H4211-sds
ACRO Quality

Part of Bioactivity data

GMP-IFGH24-Cell-based assay
 IFN-gamma CELL

GMP Human IFN-gamma Protein (Cat. No. GMP-IFGH24) inhibits the proliferation of HT-29 cells. The specific activity of GMP Human IFN-gamma Protein is > 2.00×10^7 IU/mg, which is calibrated against human interferon gamma Standard (NIBSC code: 87/586) (QC tested).

IFG-H4211-Cell-based assay
 IFN-gamma CELL

Human IFN-gamma, premium grade (Cat. No. IFG-H4211) inhibits the proliferation of HT-29 cells. The specific activity of Human IFN-gamma, premium grade is > 2.00×10^7 IU/mg, which is calibrated against human interferon gamma Standard (NIBSC code: 87/586) (QC tested).

Biotinylated Monoclonal Anti-IFNγ Antibody, Mouse IgG1 (13E6H6) (Cat. No. IFN-BS138) captured on CM5 chip via anti-mouse antibodies surface can bind Human IFN-gamma, premium grade (Cat. No. IFG-H4211) with an affinity constant of 1.28 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Monoclonal Anti-IFNγ antibody, Mouse IgG2a (8C5F8) (Cat. No. IFN-S120) captured on CM5 chip via anti-mouse antibodies surface can bind Human IFN-gamma, premium grade (Cat. No. IFG-H4211) with an affinity constant of 0.933 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

Synonym Name

Interferon-gamma ,Interferon-γ

Background

Interferon-gamma (IFN-γ/IFNG) is a dimerized soluble cytokine that is the only member of the type II class of interferon. This interferon was originally called macrophage-activating factor, a term now used to describe a larger family of proteins to which IFN-γ belongs. IFN-gamma has been used in a wide variety of clinical indications. Interferon-gamma (IFNgamma) is a central regulator of the immune response and signals via the Janus Activated Kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) pathway. Interferon gamma has broader roles in activation of innate and adaptive immune responses to viruses and tumors, in part through upregulating transcription of genes involved in cell cycle regulation, apoptosis, and antigen processing/presentation. Despite this, rodent and human trophoblast cells show dampened responses to IFNG that reflect the resistance of these cells to IFNG-mediated activation of major histocompatibility complex (MHC) class II transplantation antigen expression.

Clinical and Translational Updates

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Cadi-05 Cadi-05 Approved National Institute Of Allergy And Infectious Diseases (Niaid) Immuvac, Leprovac, Mycidac-C India Carcinoma, Non-Small-Cell Lung; Leprosy null 1998-01-01 Leprosy; Carcinoma, Non-Small-Cell Lung Details
Emapalumab NI-0501 Approved Novimmune Sa Gamifant United States Lymphohistiocytosis, Hemophagocytic Novimmune Sa 2018-11-20 Macrophage Activation Syndrome; Still's Disease, Adult-Onset; Rare Diseases; Immune System Diseases; Arthritis, Juvenile; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic Details
Thalidomide NSC-66847; NSC-527179; K-17; VP-02; FPF-300; FPF300 Approved Celgene Corp Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled Mainland China Leprosy, Lepromatous; Multiple Myeloma Changzhou Pharmaceutical Factory 1982-01-01 HIV Wasting Syndrome; Angiodysplasia; Primary Myelofibrosis; Neuroectodermal Tumors, Primitive; Prostatitis; Colorectal Neoplasms; Osteosarcoma; Lymphoma, Mantle-Cell; Sarcoma, Ewing; Retinoblastoma; Erythema Nodosum; Drug Resistant Epilepsy; Xerostomia; Sarcoma; Pancreatitis, Chronic; Adenocarcinoma, Clear Cell; Lymphoma, Follicular; Arachnoiditis; Carcinoma, Adenosquamous; Gastrointestinal Hemorrhage; Cholangitis, Sclerosing; Prostatic Neoplasms; Pelvic Pain; Neoplasm Metastasis; Stomatitis; Burning Mouth Syndrome; Mycobacterium avium-intracellulare Infection; Amyotrophic Lateral Sclerosis; Melanoma; Myelodysplastic-Myeloproliferative Diseases; Carcinoma, Hepatocellular; Leukemia, Lymphocytic, Chronic, B-Cell; Vascular Malformations; Tuberculosis; Appendiceal Neoplasms; Lymphoma, Non-Hodgkin; Uterine Neoplasms; Anemia, Sideroblastic; Glioma; Leprosy, Lepromatous; Endometrial Neoplasms; Lung Neoplasms; Waldenstrom Macroglobulinemia; Kidney Neoplasms; Thalassemia; Carcinoid Tumor; Lupus Erythematosus, Discoid Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Tadekinig alfa (AB2 Bio) Phase 3 Clinical Ab2 Bio Ltd Macrophage Activation Syndrome; Cytokine Release Syndrome; Lymphohistiocytosis, Hemophagocytic Details
PDS-0101 PDS-0101B; PDS-0101C; PDS-0101; PDS-0101A; PDS-101 Phase 2 Clinical Pds Biotechnology Corporation, Merck Serono Head and Neck Neoplasms; Anus Neoplasms; Papillomavirus Infections; Vulvar Neoplasms; Oropharyngeal Neoplasms; Carcinoma, Squamous Cell; Uterine Cervical Neoplasms Details
YH-32367 ABL105; YH-32367 Phase 2 Clinical Abl Bio Inc Solid tumours; Stomach Neoplasms; Breast Neoplasms Details
OCH-NCNP1 OCH-NCNP1 Phase 2 Clinical Keio University Multiple Sclerosis; Crohn Disease Details
KIO-101(Kiora) PP-001; KIO-101 Phase 2 Clinical 4sc Ag Dry Eye Syndromes; Eye Diseases; Keratoconjunctivitis; Uveitis; Xerophthalmia; Conjunctival Diseases Details
ASN-002 (Ascend Biopharmaceuticals) TG-1042; Ad-IFNγ; SP-002 (Ascend Biopharmaceuticals) Phase 2 Clinical Transgene Sa Solid tumours; Lymphoma, B-Cell; Carcinoma, Basal Cell; Skin Neoplasms; Basal Cell Nevus Syndrome; Melanoma Details
IFN-gamma-secreting HAdV antigen specific T cells (Case Comprehensive Cancer Center) Phase 1 Clinical Case Comprehensive Cancer Center Hematopoietic stem cell transplantation (HSCT) Details
Recombinant human interferon gamma adenovirus injection (Guangzhou Dabo Biological Products) Phase 1 Clinical Guangzhou Dabo Biological Products Co Ltd Liver Neoplasms; Nasopharyngeal Neoplasms; Prostatic Neoplasms, Castration-Resistant Details
EI-001 EI-001 Phase 1 Clinical Elixiron Immunotherapeutics Inc Vitiligo Details

This web search service is supported by Google Inc.

totop

Laisser un message